Page last updated: 2024-10-27

fluorouracil and Mixed Tumor, Malignant

fluorouracil has been researched along with Mixed Tumor, Malignant in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Mixed Tumor, Malignant: A malignant tumor composed of more than one type of neoplastic tissue. (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, Z1
Chen, J1
Guo, Y1
Precetti, FA1
Prieto, Mde C1
Pietrantonio, A1
González, B1

Other Studies

2 other studies available for fluorouracil and Mixed Tumor, Malignant

ArticleYear
Efficacy of XELOX adjuvant chemotherapy for gastric mixed adenoneuroendocrine carcinoma: A case report.
    Medicine, 2019, Volume: 98, Issue:23

    Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Neuroendocrine; Ch

2019
[Mixed carcinoid-adenocarcinoma in transverse colon].
    Acta gastroenterologica Latinoamericana, 2010, Volume: 40, Issue:4

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Carcinoid Tumor; Colon, Transverse; Colonic N

2010